Drug-delivery platform that shuttles therapeutic payloads directly into tumor-cell cytosol via a synthetic shuttle with pan-cancer uptake, endosomal escape, high intracellular exposure, and sustained tumor retention. Compatible with small and large molecules such as nanobody therapeutics and tumor-directed cytotoxics to unlock undruggable intracellular oncogenes and expand therapeutic windows for cancer patients.